MedPath

Acupuncture for Fibromyalgia

Not Applicable
Conditions
Fibromyalgia
Interventions
Device: Verum acupuncture (30# acupuncture needle)
Device: Sham acupuncture
Registration Number
NCT02583334
Lead Sponsor
China Medical University Hospital
Brief Summary

Fibromyalgia is the second most common autoimmune rheumatic diseases with clinical manifestations of widespread pain, fatigue and accompanied cognitive and emotional disturbances. It often associated with sleep disorders and headaches. The cardinal symptom of fibromyalgia is widespread pain. Clinical observations reveal that pain in patients with fibromyalgia could not simply improve by using analgesics only. Patients often use Chinese medicine or acupuncture to help them to ease the pain.

The aim of this study is to investigate the efficacy of acupuncture in patients with fibromyalgia. The study adapted a randomized, assessor- and participant-blinded, sham-controlled, and parallel-design approach to investigate whether acupuncture can improve the clinical symptoms and quality of life as well as the mechanism through laboratory biochemistric and image study.

Detailed Description

A total of 158 volunteers of patients with fibromyalgia will be recruited from the Chinese medicine or Western medicine clinics in China Medical University Hospital(Taichung and other affiliated branches). After diagnosis by rheumatologist, these patients will be randomized to receive verum acupuncture or sham acupuncture treatment, three times a week, for 4 weeks (12 treatment in total). Visual analogue scale will be done for every visit. Laboratory biochemistric analysis and other questionnaires including Visual Analogue Scale, Fibromyalgia Impact Questionnaire, SF-36 health survey, Pittsburgh Sleep Quality Index and Beck Depression Inventory-II will be completed at baseline, 2, 4 weeks after initiation of intervention (complete acupuncture treatment), 4 weeks after completion of acupuncture completion (8 weeks). PET image examination (optional; this item depends on patients' own will) and instrumental examinations including heart rate variability and traditional Chinese medicine four examinations will be given before and after intervention. We expect that the efficacy of verum acupuncture is superior to sham acupuncture in improving pain, fatigue, physical function and quality of life. The effectiveness of acupuncture can be detected by questionnaires. Moreover, we will further speculate the mechanism by analyzing laboratory and image data.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
158
Inclusion Criteria
  1. Participants met the diagnostic criteria (American College of Rheumatology, 2011) and were diagnosed fibromyalgia.
  2. Persisted pain for more than 50 percent of time.
  3. Adult volunteers of ages between 20~75 years old.
  4. Male or female genders.
  5. No allergy or contraindication to stainless needles.
  6. Participants understood the aim and process of the trial, agreed to participate in trial as well as completed informed consent.
Exclusion Criteria
  1. More than 75 or less than 20 years old.
  2. Had used opioid or narcotic analgesic drugs within one month before the beginning of trial.
  3. Had used Pregabalin within 6 months.
  4. Drug abuse.
  5. Coagulation dysfunction or low platelet count in blood tests(platelet≤150000 / uL).
  6. Other diagnosed rheumatoid comorbidities such as rheumatoid arthritis, systemic lupus erythema, inflammatory bowel disease, autoimmune thyroiditis.
  7. Participating in other clinical trials.
  8. Pregnancy or lactation.
  9. Severe psychological or behavioral disorders such as schizophrenia.
  10. Arrhythmia patients with pacer marker.
  11. Severe diseases such as myocardial infarction, severe arrhythmia,cardiac arrest, chronic obstructive pulmonary disease, renal failure and cancers.
  12. Limbs edema and severe skin lesions contraindicated to acupuncture.
  13. Had Chinese medicine or acupuncture within two weeks prior to the beginning of trial.
  14. Had not completed informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Verum AcupunctureVerum acupuncture (30# acupuncture needle)After diagnosis by rheumatologist, participants will be randomized to receive verum acupuncture or sham acupuncture treatment. In the verum acupuncture group, participants will receive verum acupuncture (Device: 30# acupuncture needle) three times a week, for 4 weeks (12 treatment in total).
Sham AcupunctureSham acupunctureAfter diagnosis by rheumatologist, participants will be randomized to receive verum acupuncture or sham acupuncture treatment. In the sham acupuncture group, participants will receive sham acupuncture (Device: Streitberger device) three times a week, for 4 weeks (12 treatment in total).
Primary Outcome Measures
NameTimeMethod
Fibromyalgia Impact Questionnaire0,2,4,8 week

Changes from baseline to midpoint、end of intervention and 4 weeks after intervention completed

Secondary Outcome Measures
NameTimeMethod
Heart rate variability0,4 week

Changes from baseline to the end of intervention

The Constitution in Chinese Medicine Questionnaire0,2,4,8 week

Changes from baseline to midpoint、end of intervention and 4 weeks after intervention completed

SF-36 health survey0,2,4,8 week

Changes from baseline to midpoint、end of intervention and 4 weeks after intervention completed

Pittsburgh Sleep Quality Index0,2,4,8 week

Changes from baseline to midpoint、end of intervention and 4 weeks after intervention completed

Beck Depression Inventory-II0,2,4,8 week

Changes from baseline to midpoint、end of intervention and 4 weeks after intervention completed

FDG PET/CT scan0, 4-6week

optional examination; changes from baseline to the 4-6week of intervention

Laboratory examination: cytokines0,4 week

Changes from baseline to the end of intervention

Hematogram0,4 week

Changes from baseline to the end of intervention

Visual Analogue Scale0,2,4,8 week

Changes from baseline to midpoint、end of intervention and 4 weeks after intervention completed

TCM four examinations0,4 week

Changes from baseline to the end of intervention

Liver function test0,4 week

Changes at baseline and end of intervention

Renal function test0,4 week

Changes from baseline to the end of intervention

Widespread pain index0,2,4,8 week

Changes from baseline to midpoint、end of intervention and 4 weeks after intervention completed

Symptom severity scale0,2,4,8 week

Changes from baseline to midpoint、end of intervention and 4 weeks after intervention completed

Trial Locations

Locations (2)

China Medical University Hospital

🇨🇳

Taichung, Taiwan

China Medical University Hospital-Taipei branch

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath